Cara Therapeutics

-$0.04 (-0.30%) Today
+$0.01 (+0.07%) As of 8:02 PM UTC after-hours

Why Robinhood?

You can buy or sell CARA and other stocks, options, and ETFs commission-free!

About CARA

Cara Therapeutics, Inc. Common Stock, also called Cara Therapeutics, is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).

CEO
Derek T. Chalmers
Employees
80
Headquarters
Stamford, Connecticut
Founded
2004

CARA Key Statistics

Market Cap
651.51M
Price-Earnings Ratio
56.63
Dividend Yield
—
Average Volume
1.25M
High Today
$13.63
Low Today
$13.33
Open Price
$13.40
Volume
381.76K
52 Week High
$29.65
52 Week Low
$11.80

CARA Earnings

-$0.74
$0.04
$0.81
$1.59
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.59 per share
Actual
-$0.47 per share
Replay Earnings Call

You May Also Like

EVOJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure